Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 6 de 6
Filter
Add more filters










Database
Publication year range
1.
Beijing Da Xue Xue Bao Yi Xue Ban ; 48(6): 1067-1073, 2016 12 18.
Article in Chinese | MEDLINE | ID: mdl-27987515

ABSTRACT

OBJECTIVE: To prepare felodipine/copovidone solid dispersions, which were made based on different preparation technologies. Insoluble felodipine was selected as the model drug in this research. This drug belonged to Biopharmaceutics Classification System II (BCSII) with insoluble property and good permeability across intestinal mucosa simultaneously. A comparative study was carried out for further investigating their corresponding pharmaceutical properties. METHODS: Felodipine/copovidone solid dispersions were achieved by four methods including spray-drying method, microwave-induced fusion quench cooling method, freeze-drying method and co-precipitation method. These solid dispersions were produced based on corresponding processes that corresponded to these methods. Internal properties of co-povidone solid dispersions were analyzed by various approaches including scanning electron microscope (SEM), differential scanning calorimetry (DSC) and powder X-ray diffraction (PXRD). The improvement on insoluble properties of felodipine by solid dispersions produced by different technologies was characterized by dissolution experiments based on dissolution instrument. Crystallization inhibition effect of polymers against drugs was studied by supersaturated experiments through determining the concentration value at different time points. RESULTS: The internal drug was dispersed in amorphous form in solid dispersions produced by spray-drying, microwave method, microwave/quench-cooling method and co-precipitation method. Freeze-drying method resulted in a form of crystal in felodipine/copovidone solid dispersions. Compared with other technologies, microwave-induced quench cooling method could significantly improve the dissolution of insoluble drug felodipine (P<0.05). The dissolution concentration reached approximately 4.65 mg/L at 60 min time point. Copovidone could inhibit or retard the crystallization of felodipine in a supersaturated state. In the solution pre-dissolved with maximum copoyidone polymer, the minimum crystallization rate of supersaturated felodipine was observed at 240 min time point. The value of crystallization rate was 0.19 mg/(L×min). CONCLUSION: The study is helpful to understand and clarify the internal properties of solid dispersions obtained by different technologies. The research also provides beneficial consultation for the choice of technology in practical production of drug-polymer solid dispersions.


Subject(s)
Drug Compounding/methods , Felodipine/chemistry , Pyrrolidines/chemistry , Solubility , Vinyl Compounds/chemistry , Calorimetry, Differential Scanning , Chemical Precipitation , Crystallization , Desiccation , Drug Carriers/chemistry , Microwaves , Polymers , Povidone , X-Ray Diffraction
2.
Appl Biochem Biotechnol ; 84-86: 201-16, 2000.
Article in English | MEDLINE | ID: mdl-10849789

ABSTRACT

Pichia stipitis CBS 6054 will grow on D-xylose, D-arabinose, and L-arabinose. D-Xylose and L-arabinose are abundant in seed hulls of maize, and their utilization is important in processing grain residues. To elucidate the degradation pathway for L-arabinose, we obtained a mutant, FPL-MY30, that was unable to grow on D-xylose and L-arabinose but that could grow on D-arabinitol. Activity assays of oxidoreductase and pentulokinase enzymes involved in D-xylose, D-arabinose, and L-arabinose pathways indicated that FPL-MY30 is deficient in D-xylitol dehydrogenase (D-XDH), D- and L-arabinitol dehydrogenases, and D-ribitol dehydrogenase. Transforming FPL-MY30 with a gene for xylitol dehydrogenase (PsXYL2), which was cloned from CBS 6054 (GenBank AF127801), restored the D-XDH activity and the capacity for FPL-MY30 to grow on L-arabinose. This suggested that FPL-MY30 is critically deficient in XYL2 and that the D-xylose and L-arabinose metabolic pathways have xylitol as a common intermediate. The capacity for FPL-MY30 to grow on D-arabinitol could proceed through D-ribulose.


Subject(s)
Arabinose/metabolism , Pichia/growth & development , Pichia/genetics , Xylose/metabolism , D-Xylulose Reductase , Genetic Complementation Test , Mutagenesis , Pichia/metabolism , Seeds , Stereoisomerism , Substrate Specificity , Sugar Alcohol Dehydrogenases/genetics , Sugar Alcohol Dehydrogenases/metabolism , Zea mays
3.
Adv Biochem Eng Biotechnol ; 65: 117-61, 1999.
Article in English | MEDLINE | ID: mdl-10533434

ABSTRACT

Xylose utilization is essential for the efficient conversion of lignocellulosic materials to fuels and chemicals. A few yeasts are known to ferment xylose directly to ethanol. However, the rates and yields need to be improved for commercialization. Xylose utilization is repressed by glucose which is usually present in lignocellulosic hydrolysates, so glucose regulation should be altered in order to maximize xylose conversion. Xylose utilization also requires low amounts of oxygen for optimal production. Respiration can reduce ethanol yields, so the role of oxygen must be better understood and respiration must be reduced in order to improve ethanol production. This paper reviews the central pathways for glucose and xylose metabolism, the principal respiratory pathways, the factors determining partitioning of pyruvate between respiration and fermentation, the known genetic mechanisms for glucose and oxygen regulation, and progress to date in improving xylose fermentations by yeasts.


Subject(s)
Genetic Engineering , Saccharomyces cerevisiae/genetics , Xylose/metabolism , Cellulose/metabolism , Ethanol/metabolism , Fermentation/genetics , Glucose/metabolism , Oxygen Consumption , Pentoses/metabolism , Pyruvic Acid/metabolism , Saccharomyces cerevisiae/physiology
4.
Yeast ; 15(11): 1021-30, 1999 Aug.
Article in English | MEDLINE | ID: mdl-10455226

ABSTRACT

The xylose-utilizing yeast, Pichia stipitis, has a complex respiratory system that contains cytochrome and non-cytochrome alternative electron transport chains in its mitochondria. To gain primary insights into the alternative respiratory pathway, a cytochrome c gene (PsCYC1, Accession No. AF030426) was cloned from wild-type P. stipitis CBS 6054 by cross-hybridization to CYC1 from Saccharomyces cerevisiae. The 333 bp open reading frame of PsCYC1 showed 74% and 69% identity to ScCYC1 and ScCYC7, respectively, at the DNA level. Disruption of PsCYC1 resulted in a mutant that uses the salicylhydroxamic acid (SHAM)-sensitive respiratory pathway for aerobic energy production. Cytochrome spectra revealed that cytochromes c and a.a(3) both disappeared in the cyc1-Delta mutant, so no electron flow through the cytochrome c oxidase was possible. The cyc1-Delta mutant showed 50% lower growth rates than the parent when grown on fermentable sugars. The cyc1-Delta mutant was also found to be unable to grow on glycerol. Interestingly, the mutant produced 0.46 g/g ethanol from 8% xylose, which was 21% higher in yield than the parental strain (0.38 g/g). These results suggested that the alternative pathway might play an important role in supporting xylose conversion to ethanol under oxygen-limiting conditions.


Subject(s)
Cytochrome c Group/genetics , Ethanol/metabolism , Pichia/metabolism , Xylose/metabolism , Antifungal Agents/chemistry , Antifungal Agents/metabolism , Base Sequence , Blotting, Southern , Cytochrome c Group/chemistry , DNA Primers , DNA, Fungal/chemistry , Electron Transport/genetics , Fermentation , Molecular Sequence Data , Mutation/genetics , Phylogeny , Pichia/genetics , Pichia/growth & development , Polymerase Chain Reaction , Salicylamides/chemistry , Salicylamides/metabolism , Sequence Alignment , Sequence Analysis, DNA
5.
Appl Microbiol Biotechnol ; 50(3): 339-45, 1998 Sep.
Article in English | MEDLINE | ID: mdl-9802219

ABSTRACT

Respiratory and fermentative pathways coexist to support growth and product formation in Pichia stipitis. This yeast grows rapidly without ethanol production under fully aerobic conditions, and it ferments glucose or xylose under oxygen-limited conditions, but it stops growing within one generation under anaerobic conditions. Expression of Saccharomyces cerevisiae URA1 (ScURA1) in P. stipitis enabled rapid anaerobic growth in minimal defined medium containing glucose when essential lipids were present. ScURA1 encodes a dihydroorotate dehydrogenase that uses fumarate as an alternative electron acceptor to confer anaerobic growth. Initial P. stipitis transformants grew and produced 32 g/l ethanol from 78 g/l glucose. Cells produced even more ethanol faster following two anaerobic serial subcultures. Control strains without ScURA1 were incapable of growing anaerobically and showed only limited fermentation. P. stipitis cells bearing ScURA1 were viable in anaerobic xylose medium for long periods, and supplemental glucose allowed cell growth, but xylose alone could not support anaerobic growth even after serial anaerobic subculture on glucose. These data imply that P. stipitis can grow anaerobically using metabolic energy generated through fermentation but that it exhibits fundamental differences in cofactor selection and electron transport with glucose and xylose metabolism. This is the first report of genetic engineering to enable anaerobic growth of a eukaryote.


Subject(s)
Oxidoreductases Acting on CH-CH Group Donors , Oxidoreductases/genetics , Pichia/growth & development , Pichia/genetics , Saccharomyces cerevisiae/genetics , Transformation, Genetic , Anaerobiosis , Culture Media , Dihydroorotate Dehydrogenase , Ethanol/metabolism , Fermentation , Genes, Fungal , Glucose/metabolism , Oxidoreductases/metabolism , Physical Chromosome Mapping , Pichia/enzymology , Plasmids/genetics , Saccharomyces cerevisiae/enzymology , Xylose/metabolism
6.
Gene ; 127(2): 199-202, 1993 May 30.
Article in English | MEDLINE | ID: mdl-8500761

ABSTRACT

We have prepared a DNA cassette containing the UMP synthase (UMPS)-encoding gene (PYR5-6) from Dictyostelium discoideum. This gene contains no introns and can be used for expression of the UMPS protein. Due to the high percentage of AT in the flanking regions, useful restriction sites were absent, therefore the PYR5-6 was subcloned as three separate parts, manipulated, and religated to make a full-length clone. After reconstructing the coding region, we examined its functionality by introducing this gene under the control of the yeast GAL1 promoter into several uracil-requiring mutants of Saccharomyces cerevisiae. These studies demonstrated that the reconstructed PYR5-6 gene was functional and could complement independent ura3 and ura5 mutations in yeast.


Subject(s)
Dictyostelium/enzymology , Dictyostelium/genetics , Multienzyme Complexes/genetics , Orotate Phosphoribosyltransferase/genetics , Orotidine-5'-Phosphate Decarboxylase/genetics , Amino Acid Sequence , Animals , Base Sequence , Cloning, Molecular , Genes, Fungal , Genes, Regulator , Genetic Complementation Test , Molecular Sequence Data , Multienzyme Complexes/metabolism , Mutagenesis, Insertional , Oligodeoxyribonucleotides , Orotate Phosphoribosyltransferase/metabolism , Orotidine-5'-Phosphate Decarboxylase/metabolism , Promoter Regions, Genetic , Restriction Mapping , Saccharomyces cerevisiae
SELECTION OF CITATIONS
SEARCH DETAIL
...